Referrals to the West Midlands Familial Hypercholesterolaemia Service can be made via the e-Referral System (eRS) from 1 September 2020
The West Midlands Familial Hypercholesterolaemia Service (WMFHS) is a direct access, nurse-led, assessment and genetic testing service launched in November 2017 and commissioned by all 20 West Midlands CCG’s. Clinics are held in primary care venues across the CCG and there is an allocated FH Specialist Nurse for each CCG across the region.
Patients can be referred to the service opportunistically or following a systematic search of GP records. Referrals should include patients with clinically diagnosed FH (based on the Simon Broome criteria) who have not had FH genetically confirmed as this enables the cascade testing of family members. Cascade testing is the process of systematically offering DNA testing to the relatives of affected individuals because someone with FH has a 50:50 chance of passing the condition on to their children. The benefits of cascade testing are early identification and early initiation of treatment to reduce the risk of premature coronary heart disease.
The business case pathway agreed by all CCGs within the West Midlands is that patients with suspected FH are referred to the West Midlands Familial Hypercholesterolaemia Service (WMFHS), assessed and genetically tested and referred to secondary care colleagues if indicated. The service undertakes cascade family screening for both adults and children.

From 1st September 2020, referrals can be made via the e-Referral System (eRS formerly Choose and Book):-
Speciality – Endocrinology and Metabolic Medicine
Clinic Type – Lipid Disorders
Referral Assessment Service (RAS)
Send for Triage and attach referral form (attached)
Referral criteria and referral form are attached for information.
Any queries should be emailed to
For more information, please contact Elaine George, Clinical Manager on 0121 371 8179 or via